Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Rectal Neoplasms 2Adenocarcinoma 1

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 290Drug Therapy 276Bevacizumab 248apatinib 247camrelizumab 219Etoposide 201Irinotecan 182Doxorubicin 181Leucovorin 163Dexamethasone 161pembrolizumab 153Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × capecitabine-irinotecan combination × Clear all
NCT04227886 2020-01-14

Study on Predictive Biomarkers of Neoadjuvant Chemoradiotherapy for Rectal Cancer

Fudan University

Unknown
250 enrolled
Gastrointestinal

Adenocarcinoma, Rectal Neoplasms

NCT00506623 2007-07-25

Preoperative Chemoradiotherapy With Capecitabine Plus Irinotecan in Rectal Cancer

National Cancer Center, Korea

Phase 2 Unknown
48 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡